What seems to have begun with the Constellation/Canopy Growth deal has evolved into something much more exciting that could further set the stage for 2018 to be a year for big M&A as well as the beginning of Blue Chip companies taking a seat at the table.
Then you have pre-IPO companies like The Green Organic Dutchman (TGOD) who are slated to go public this year after raising their own pool of funds. I spoke briefly about this as well as MedMen, which is another company set to IPO May 2. TGOD has already raised some $160 million dollars from over 4,000 shareholders so far.
Aurora will ultimately acquire a 17.62% interest of TGOD on a non-diluted basis valued at a healthy $55 million alone. In this case, the raise done by TGOD is more focused on growth of its production capacity and being able to largely scale out its operations for various supply contracts.